Discover
PMVP
PMV Pharmaceuticals, Inc.
1.47
2 x 1.09
2 x 1.86
bid
ask
-
0.03
2.00%
10:23 AM
timesize
| Ytd | 17.60% | |
| 1y | 12.21% |
1.46
day range
1.51
1.02
52 week range
1.88
| Open | 1.50 | Prev Close | 1.50 | Low | 1.46 | High | 1.51 | Mkt Cap | 78.58M |
| Vol | 102.19K | Avg Vol | 512.27K | EPS | -1.42 | P/E | N/A | Forward P/E | -0.96 |
| Beta | 1.37 | Short Ratio | 5.17 | Inst. Own | 83.89% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-16 | 50-d Avg | 1.28 | 200-d Avg | 1.27 | 1yr Est | 5.80 |
| Income Statement | |||
| Operating Expenses | 18.88M | ||
| Research and Development Expense | 14.68M | ||
| Selling, General and Administrative Expense | 4.21M | ||
| Operating Income | -18.88M | ||
| Income Tax Expense | 3.00K | ||
| Net Income | -18.09M | ||
| Net Income Common Stock | -18.09M | ||
| Net Income Common Stock (USD) | -18.09M | ||
| Consolidated Income | -18.09M | ||
| Earnings per Basic Share | -0.34 | ||
| Earnings per Basic Share (USD) | -0.34 | ||
| Earnings per Diluted Share | -0.34 | ||
| Earning Before Interest & Taxes (EBIT) | -18.08M | ||
| Earning Before Interest & Taxes (USD) | -18.08M | ||
| Weighted Average Shares | 53.39M | ||
| Weighted Average Shares Diluted | 53.39M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.47M | ||
| Cash and Equivalents (USD) | 12.47M | ||
| Investments | 66.96M | ||
| Investments Current | 66.96M | ||
| Current Assets | 81.41M | ||
| Property, Plant & Equipment Net | 363.00K | ||
| Total Assets | 82.07M | ||
| Debt Current | 217.00K | ||
| Total Debt | 217.00K | ||
| Current Liabilities | 10.57M | ||
| Total Liabilities | 10.57M | ||
| Accumulated Retained Earnings (Deficit) | -482.58M | ||
| Accumulated Other Comprehensive Income | -82.00K | ||
| Shareholders Equity | 71.50M | ||
| Shareholders Equity (USD) | 71.50M | ||
| Assets Non-Current | 659.00K | ||
| Total Debt (USD) | 217.00K | ||
| Trade and Non-Trade Payables | 2.02M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 24.00K | ||
| Net Cash Flow from Financing | 143.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -26.66M | ||
| Issuance (Purchase) of Equity Shares | 143.00K | ||
| Net Cash Flow from Investing | -12.23M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -12.23M | ||
| Net Cash Flow from Operations | -14.58M | ||
| Share Based Compensation | 1.54M | ||